Glaukos - Stock

Glaukos ROA 2024

Glaukos ROA

-0.14

Ticker

GKOS

ISIN

US3773221029

WKN

A14VCK

In 2024, Glaukos's return on assets (ROA) was -0.14, a 44.69% increase from the -0.1 ROA in the previous year.

Glaukos Aktienanalyse

What does Glaukos do?

Glaukos Corp is a medical technology company specializing in developing devices and therapies for treating eye diseases. It was founded in 1998 by employees of the ophthalmology center at the University of California San Francisco. The company focuses on utilizing new technologies and therapies to improve the vision quality of patients. They have developed innovative products for diagnosing and treating various eye conditions, including glaucoma. Their core business involves manufacturing and distributing medical devices for glaucoma treatment, such as the iStent implant. They have also partnered with other institutions to advance research and development in the field of ophthalmology. In 2018, Glaukos Corp acquired the German manufacturer Markt II Medical, expanding their product offerings for a wider range of eye diseases. In summary, Glaukos Corp is an innovative medical technology company that aims to enhance patients' vision quality while minimizing the risks of eye surgery. Glaukos ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Glaukos's Return on Assets (ROA)

Glaukos's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Glaukos's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Glaukos's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Glaukos’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Glaukos stock

What is the Return on Assets (ROA) of Glaukos this year?

The Return on Assets (ROA) of Glaukos is -0.14 undefined this year.

What was the ROA of Glaukos compared to the previous year?

The ROA of Glaukos has increased by 44.69% compared to the previous year.

What consequences do high ROA have for investors of Glaukos?

A high ROA is advantageous for investors of Glaukos, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Glaukos?

A low ROA can be unfavorable for investors of Glaukos as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Glaukos affect the company?

An increase in ROA of Glaukos can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Glaukos impact the company?

A reduction in the ROA of Glaukos can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Glaukos?

Some factors that can influence the ROA of Glaukos include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Glaukos important for investors?

The ROA of Glaukos is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Glaukos take to improve ROA?

To improve ROA, Glaukos can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Glaukos pay?

Over the past 12 months, Glaukos paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Glaukos is expected to pay a dividend of 0 USD.

What is the dividend yield of Glaukos?

The current dividend yield of Glaukos is .

When does Glaukos pay dividends?

Glaukos pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Glaukos?

Glaukos paid dividends every year for the past 0 years.

What is the dividend of Glaukos?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Glaukos located?

Glaukos is assigned to the 'Health' sector.

Wann musste ich die Aktien von Glaukos kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Glaukos from 7/7/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/7/2024.

When did Glaukos pay the last dividend?

The last dividend was paid out on 7/7/2024.

What was the dividend of Glaukos in the year 2023?

In the year 2023, Glaukos distributed 0 USD as dividends.

In which currency does Glaukos pay out the dividend?

The dividends of Glaukos are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Glaukos

Our stock analysis for Glaukos Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Glaukos Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.